I take from this that what’s reported were the best responses at any time on trial, according to Recist criteria. Ultimately all patients progress, my hunch is that those that left the trial is because they progressed and maybe gone onto other chemo, or maybe another clinical trial. The 3 remaining haven’t progressed yet.
- Forums
- ASX - By Stock
- Ann: Update on ACCENT Trial in Pancreatic Cancer
I take from this that what’s reported were the best responses at...
-
- There are more pages in this discussion • 33 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ATX (ASX) to my watchlist
(20min delay)
|
|||||
Last
6.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $18.19M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 150000 | 6.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.6¢ | 150000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 150000 | 0.065 |
1 | 13334 | 0.062 |
4 | 60000 | 0.060 |
1 | 79000 | 0.057 |
4 | 356818 | 0.055 |
Price($) | Vol. | No. |
---|---|---|
0.066 | 150000 | 1 |
0.067 | 43311 | 2 |
0.068 | 157750 | 1 |
0.070 | 6009 | 1 |
0.074 | 73026 | 1 |
Last trade - 16.12pm 19/06/2024 (20 minute delay) ? |
Featured News
ATX (ASX) Chart |
Day chart unavailable
The Watchlist
INF
INFINITY LITHIUM CORPORATION LIMITED
Ryan Parkin, Managing Director & CEO
Ryan Parkin
Managing Director & CEO
Previous Video
Next Video
SPONSORED BY The Market Online